Your session is about to expire
← Back to Search
Spanish-Language Hearing Loss Toolkit for Hearing Loss
N/A
Recruiting
Led By Victoria Sanchez, Au.D., Ph.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed 4-6 weeks post baseline assessment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether Spanish-language hearing education materials help adults better understand their hearing loss and how to manage it.
Who is the study for?
This trial is for Spanish-speaking adults over 50 who identify as Hispanic/Latino, have significant hearing loss or difficulty hearing. To join, they must experience more than a mild level of hearing loss across various pitches or report substantial hearing challenges.
What is being tested?
The study is testing educational materials in Spanish designed to help participants understand and manage their hearing loss better. It compares the effectiveness of a new toolkit against existing ASHA audiology handouts.
What are the potential side effects?
Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating in this study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed 4-6 weeks post baseline assessment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 4-6 weeks post baseline assessment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Self-Efficacy for Chronic Health Condition Management (generic )
Hearing impairment
Secondary study objectives
Hearing Loss Knowledge, Attitudes, and Behaviors
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
This group will receive the Spanish-Language Hearing Loss Toolkit materials.
Group II: Active Control GroupActive Control1 Intervention
This group will receive standard of care Spanish language information from the American Speech-Language-Hearing Association (ASHA) Audiology Series
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
426 Previous Clinical Trials
191,729 Total Patients Enrolled
8 Trials studying Hearing Loss
1,383 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
354 Previous Clinical Trials
181,625 Total Patients Enrolled
60 Trials studying Hearing Loss
21,380 Patients Enrolled for Hearing Loss
Victoria Sanchez, Au.D., Ph.D.Principal InvestigatorUniversity of South Florida
Michelle Arnold, Au.D., Ph.D.Principal InvestigatorUniversity of South Florida
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 50, Hispanic/Latino, and speak Spanish.You have trouble hearing and it is confirmed by a hearing test or by reporting significant difficulty with hearing.
Research Study Groups:
This trial has the following groups:- Group 1: Active Control Group
- Group 2: Experimental Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.